The third Nickel-dependent enzyme class in human pathogens, after Urease and Hydrogenase. Glyoxalase I detoxifies methylglyoxal, a reactive and toxic byproduct of glycolysis.

While less well-known than urease or hydrogenase as a virulence factor, GloI is emerging as a significant drug target because of a striking difference between host and pathogen: human GloI uses zinc, while pathogen GloI uses nickel. This metal selectivity difference creates an opportunity for selective inhibitors.

Evidence map3 cited passagesInspect provenance +
01
Confirmed Ni-GloI pathogens

The following pathogens have been experimentally confirmed or strongly predicted to possess Ni-dependent GloI:

02
Eukaryotic pathogens with Ni-GloI

Leishmania donovani: the glo-I gene is ESSENTIAL—glo-I mutants show reduced methylglyoxal detoxification and are not viable. This makes GloI a validated and proposed drug target for visceral leishmaniasis.

03
NEC-associated pathogens

In the preterm gut, Ni-activated GloI helps NEC-associated E. coli survive metabolic stress during the inflammatory cascade of necrotizing enterocolitis. Dietary nickel from infant formula provides the cofactor that activates this survival enzyme.

Contents1. Biochemistry2. The Ni-Dependent GloI in Pathogens3. Role in Pathogenesis4. Therapeutic Potential5. Connection to Nickel Biology6. Connections

Biochemistry#

The glyoxalase system#

The glyoxalase system is a two-enzyme detoxification pathway present in virtually all organisms:

  1. Glyoxalase I (GloI) / lactoylglutathione lyase (EC 4.4.1.5): catalyzes the isomerization of the hemithioacetal formed spontaneously between methylglyoxal and glutathione (GSH) to S-D-lactoylglutathione.
  2. Glyoxalase II (GloII) / hydroxyacylglutathione hydrolase: hydrolyzes S-D-lactoylglutathione to D-lactate, regenerating free GSH.

> Methylglyoxal + GSH --> (spontaneous) hemithioacetal --> (GloI) S-D-lactoylglutathione --> (GloII) D-lactate + GSH

Why methylglyoxal is dangerous#

Methylglyoxal (MG) is an unavoidable byproduct of glycolysis, produced primarily from the non-enzymatic decomposition of the triose phosphate intermediates dihydroxyacetone phosphate (DHAP) and glyceraldehyde-3-phosphate (G3P). MG is a potent electrophile that.

Modifies DNA: forms adducts with guanine (mutagenic). Modifies proteins: glycates arginine and lysine residues, forming advanced glycation end-products (AGEs). Crosslinks proteins: inactivates enzymes and structural proteins.

Induces apoptosis: at high concentrations.

Without GloI, methylglyoxal accumulates to lethal concentrations during active glycolysis. Any rapidly growing pathogen is under constant methylglyoxal stress.

Two distinct GloI classes—the metal selectivity divide#

This is the central biochemical insight for pathogen biology:

FeatureEukaryotic/mammalian GloIProkaryotic/pathogen GloI
Metal cofactorzinc(II) (Zn2+)nickel(II) (Ni2+) (or cobalt(II) (Co2+))
Quaternary structureHomodimerHomodimer
Active site1 zinc per subunit1 nickel (or cobalt) per subunit
DistributionMammals, plants, yeastBacteria, protozoan parasites
RepresentativeHuman GloI (GLO1)E. coli GlxI, P. aeruginosa GloI

The Ni2+-dependent GloI class is activated by nickel or cobalt but not by zinc. Conversely, the Zn2+-dependent class is activated by zinc but not by nickel. This metal selectivity is determined by the active-site geometry and ligand environment and represents a deep evolutionary divergence.

The Ni-Dependent GloI in Pathogens#

Confirmed Ni-GloI pathogens#

The following pathogens have been experimentally confirmed or strongly predicted to possess nickel (Ni)-dependent GloI:[1]Role of Nickel in Microbial PathogenesisRobert J. Maier, Stéphane L. Benoit · 2019Open reference 1 ↓

Bacterial pathogens. Pseudomonas aeruginosa: nickel-GloI characterized biochemically; detoxifies methylglyoxal during rapid growth in the CF lung and wound infections. *Neisseria meningitidis*: nickel-GloI confirmed; relevant to meningococcal meningitis. Neisseria gonorrhoeae: nickel-GloI; relevant to gonorrhea pathogenesis.

Yersinia pestis: nickel-GloI; the plague agent must maintain glycolytic flux during explosive growth in the host. Clostridium acetobutylicum: nickel-GloI co-crystallized with nickel—providing direct structural evidence for the nickel active site. Other Clostridia: including pathogenic species such as C. difficile (predicted).

Predicted nickel-GloI across Enterobacteriaceae (based on genome analysis). Escherichia coli (GlxI experimentally confirmed to require nickel(II)). Enterobacter spp. Klebsiella spp. (including K. pneumoniae).

Morganella spp. Proteus mirabilis and Proteus spp. Providencia spp.

Serratia spp. Salmonella enterica serovar Typhimurium and Salmonella spp.

This means ALL Enterobacteriaceae—the dominant family of Gram-negative pathogens—are expected to use nickel-GloI for methylglyoxal detoxification.

Eukaryotic pathogens with Ni-GloI#

The nickel (Ni)-dependent GloI class is not restricted to prokaryotes. It has been identified in protozoan parasites. Leishmania major: nickel-GloI characterized.

Trypanosoma cruzi: nickel-GloI identified (Chagas disease agent).

Leishmania donovani: the glo-I gene is ESSENTIAL—glo-I mutants show reduced methylglyoxal detoxification and are not viable. This makes GloI a validated and proposed drug target for visceral leishmaniasis.[1]Role of Nickel in Microbial PathogenesisRobert J. Maier, Stéphane L. Benoit · 2019Open reference 1 ↓

The presence of nickel-GloI in both prokaryotic and eukaryotic pathogens suggests this metal preference predates the prokaryote-eukaryote split or arose through horizontal gene transfer in parasitic lineages.

Role in Pathogenesis#

Methylglyoxal detoxification under metabolic stress#

During infection, pathogens frequently experience conditions that increase glycolytic flux and methylglyoxal production. Nutrient limitation: forces reliance on glucose catabolism. Oxidative Stress: damages metabolic enzymes, leading to triose phosphate accumulation. Rapid growth: during acute infection, high glycolytic throughput generates more methylglyoxal.

Inflammatory environment: the host oxidative burst and nutrient restriction compound metabolic stress.

nickel (Ni)-GloI maintains the pathogen's metabolic flux by preventing methylglyoxal from accumulating to toxic levels. Without functional GloI, the pathogen's own glycolysis becomes self-poisoning.

NEC-associated pathogens#

In the preterm gut, nickel (Ni)-activated GloI helps NEC-associated E. coli survive metabolic stress during the inflammatory cascade of necrotizing enterocolitis.[2]Nickel as a Catalytic Driver of Necrotizing Enterocolitis: Dietary Nickel, Microbial Metallomics, and the Activation of Nickel-Dependent Virulence Pathways in the Preterm GutKaren Pendergrass · 2026Open reference 2 ↓ Dietary nickel from infant formula provides the cofactor that activates this survival enzyme.

Potassium efflux#

In E. coli, the GloI product S-D-lactoylglutathione has been demonstrated to stimulate potassium efflux through KefB and KefC channels. This potassium release. Acidifies the cytoplasm.

Activates protective stress responses. May function as a signaling molecule coordinating metabolic stress with ion homeostasis.

This means GloI has downstream effects beyond simple detoxification—it connects methylglyoxal metabolism to cellular ion balance and stress signaling.

Therapeutic Potential#

The selective inhibitor opportunity#

The most compelling therapeutic angle for nickel (Ni)-GloI is the metal selectivity difference between host and pathogen. Human GloI: zinc (Zn)-dependent. Essential for human cells (GLO1 deficiency is linked to diabetic complications and AGE accumulation).

Pathogen GloI: nickel-dependent. Same reaction, different metal, different active-site architecture.

This means it should be possible to design selective inhibitors that target the nickel-dependent active site without affecting human zinc-GloI. The structural differences between the two metal-binding sites provide a basis for selectivity.

Drug target validation in Leishmania#

Leishmania donovani provides the strongest drug target validation. The glo-I gene is essential for viability—knockout mutants are lethal. Visceral leishmaniasis (kala-azar) kills an estimated 20,000-30,000 people annually.

Current treatments (antimonials, amphotericin B, miltefosine) have significant toxicity and resistance problems.

A nickel (Ni)-GloI-specific inhibitor could be a novel antileishmanial drug class with a completely new mechanism of action.

Broader anti-infective potential#

If selective nickel (Ni)-GloI inhibitors can be developed, they could theoretically target. All Enterobacteriaceae (including multidrug-resistant E. coli, Klebsiella, Salmonella). P. aeruginosa (including carbapenem-resistant strains).

Neisseria species (meningitis, gonorrhea).

Yersinia pestis (plague). Protozoan parasites (Leishmania, Trypanosoma).

This breadth of potential targets makes nickel-GloI inhibitor development an attractive but underexplored anti-infective strategy.

Connection to Nickel Biology#

Nickel ties GloI to the broader urease/hydrogenase story#

GloI extends the nickel-pathogen narrative beyond the well-characterized Urease and hydrogenase systems. While urease and hydrogenase have obvious virulence phenotypes (acid survival, energy generation, CagA translocation), GloI represents a more subtle dependency: metabolic housekeeping that enables sustained pathogen growth.

A pathogen colonizing a host needs all three. Urease to survive acid stress. Hydrogenase to generate energy from H2.

GloI to detoxify the methylglyoxal produced by its own glycolysis.

All three require nickel. This means nickel restriction (dietary, chelation-based, or host-mediated) potentially disables three independent virulence/survival pathways simultaneously.

Mis-metallation in reverse#

The host-vs-pathogen metal selectivity of GloI is a striking example of what might be called Mis-Metallation in reverse. Normally, mis-metallation refers to the wrong metal being inserted into an enzyme (e.g., manganese replacing iron under oxidative stress).

With GloI, the same enzyme performs the same reaction but has evolved to use different metals in host (zinc (Zn)) vs. pathogen (nickel (Ni)). This is not mis-metallation but rather divergent metallation—the same protein fold adapted to different metal environments.

The pathogen GloI's preference for nickel may reflect the generally lower zinc availability and higher nickel availability in microbial evolutionary niches (soil, water, gut lumen) compared to the zinc-rich, nickel-poor mammalian intracellular environment.

Connections#

Generated evidence record

References 6

Numbered by first appearance in the article, then reconciled with its declared source list.

  1. 1

    ★Robert J. Maier, Stéphane L. Benoit (2019). Role of Nickel in Microbial Pathogenesis. Inorganics.

  2. 2

    Karen Pendergrass (2026). Nickel as a Catalytic Driver of Necrotizing Enterocolitis: Dietary Nickel, Microbial Metallomics, and the Activation of Nickel-Dependent Virulence Pathways in the Preterm Gut. Zenodo Preprint.

  3. 3

    Karen Pendergrass (2026). Pendergrass 2026 — Endometriosis Conference Presentation (Amsterdam). Conference Presentation.

  4. 4

    Xuening Chang, Yuchen Zhang, Xue Chen et al. (2024). Chang 2024 — Gut Microbiome and Serum Amino Acid Metabolome Alterations in ASD. Nature Scientific Reports.

  5. 5

    Genchi G, Carocci A, Lauria G et al. (2020). Genchi 2020 — Nickel: Human Health and Environmental Toxicology. International Journal of Environmental Research and Public Health.

  6. 6

    ★Stéphane L. Benoit, Alan A. Schmalstig, John Glushka et al. (2019). Benoit et al. 2019 — Nickel Chelation Therapy as an Approach to Combat Multi-Drug Resistant Enteric Pathogens. Scientific Reports.

Knowledge graph

Article network

Researcher discussion

Connect the evidence

Publicly readable discussion by ORCID-authenticated researchers. Questions, interpretation, methods, corrections, and new evidence stay attached to this record.

0 posts

No discussion yet. Start with a precise question or a source-backed observation.

Transparent record

Published page changes

This record shows only material changes published on this page, including changes to its content, evidence, conclusions, or author context. Internal processes and discussion activity are excluded. Pending, declined, and withdrawn proposals remain private.

7 changes
  1. published revision

    Revised “Methylglyoxal detoxification under metabolic stress”: now reads “forces reliance on glucose catabolism. - oxidative stress: damages metabolic enzymes, leading to”.

    Revised “Methylglyoxal detoxification under metabolic stress”: changed “forces reliance on glucose catabolism. - Oxidative stress: damages metabolic enzymes, leading to” to “forces reliance on glucose catabolism. - oxidative stress: damages metabolic enzymes, leading to”. · Karen Pendergrass · +1 −1

    Inspect exact Git diff ↗
  2. published revision

    Revised “Connections”: now reads “third dimension to nickel-dependent virulence - metal dependent virulence -- GloI as”.

    Revised “Connections”: changed “third dimension to nickel-dependent virulence - Hydrogenase -- the second Ni-enzyme; GloI completes the triad - metal dependent virulence -- GloI as” to “third dimension to nickel-dependent virulence - metal dependent virulence -- GloI as”. · Karen Pendergrass · +0 −1

    Inspect exact Git diff ↗
  3. published revision

    Revised “Connections”: now reads “third dimension to nickel-dependent virulence - Hydrogenase -- the second Ni-enzyme; GloI completes”.

    Revised “Connections”: changed “third dimension to nickel-dependent virulence - hydrogenase -- the second Ni-enzyme; GloI completes” to “third dimension to nickel-dependent virulence - Hydrogenase -- the second Ni-enzyme; GloI completes”. · Karen Pendergrass · +2 −2

    Inspect exact Git diff ↗
  4. published revision

    Added references: pendergrass-2026-endometriosis-conference; chang-2024-metabolome-amino-acids-asd; genchi-2020-nickel-human-health-environmental-toxicology; benoit-2019-nickel-chelation-therapy-mdr-enteric-pathogens; maier-2019-nickel-microbial-pathogenesis;…

    Added references: pendergrass-2026-endometriosis-conference; chang-2024-metabolome-amino-acids-asd; genchi-2020-nickel-human-health-environmental-toxicology; benoit-2019-nickel-chelation-therapy-mdr-enteric-pathogens; maier-2019-nickel-microbial-pathogenesis; pendergrass-2026-nickel-nec-preterm-gut. Removed references: maier-2019-nickel-microbial-pathogenesis.md; pendergrass-2026-nickel-nec-preterm-gut.md. · WikiBiome Deploy Bot · +51 −47

    Inspect exact Git diff ↗
  5. published revision

    Revised “Confirmed Ni-GloI pathogens”: now reads “or strongly predicted to possess Ni-dependent GloI: Bacterial pathogens: - pseudomonas aeruginosa: Ni-GloI”.

    Revised “Confirmed Ni-GloI pathogens”: changed “or strongly predicted to possess Ni-dependent GloI ]: Bacterial pathogens: - pseudomonas aeruginosa: Ni-GloI” to “or strongly predicted to possess Ni-dependent GloI: Bacterial pathogens: - pseudomonas aeruginosa: Ni-GloI”. Revised “Eukaryotic pathogens with Ni-GloI”: changed “and proposed drug target for visceral leishmaniasis ]. The presence of Ni-GloI in both” to “and proposed drug target for visceral leishmaniasis. The presence of Ni-GloI in both”. Revised “NEC-associated pathogens”: changed “during the inflammatory cascade of necrotizing enterocolitis ]. Dietary nickel from infant formula provides” to “during the inflammatory cascade of necrotizing enterocolitis. Dietary nickel from infant formula provides”. Added citations to “Confirmed Ni-GloI pathogens”: maier 2019 nickel microbial pathogenesis. Removed citations from “Confirmed Ni-GloI pathogens”: [maier 2019 nickel microbial pathogenesis. Added citations to “Eukaryotic pathogens with Ni-GloI”: maier 2019 nickel microbial pathogenesis. Removed citations from “Eukaryotic pathogens with Ni-GloI”: [maier 2019 nickel microbial pathogenesis. Added citations to “NEC-associated pathogens”: pendergrass 2026 nickel nec preterm gut. Removed citations from “NEC-associated pathogens”: [pendergrass 2026 nickel nec preterm gut. · WikiBiome Deploy Bot · +5 −3

    Inspect exact Git diff ↗
  6. published revision

    Revised “Confirmed Ni-GloI pathogens”: now reads “CF lung and wound infections. - Neisseria meningitidis: Ni-GloI confirmed; relevant to meningococcal meningitis.”.

    Revised “Confirmed Ni-GloI pathogens”: changed “CF lung and wound infections. - Neisseria meningitidis: Ni-GloI confirmed; relevant to meningococcal meningitis.” to “CF lung and wound infections. - Neisseria meningitidis: Ni-GloI confirmed; relevant to meningococcal meningitis.”. · WikiBiome Deploy Bot · +1 −1

    Inspect exact Git diff ↗
  7. published revision

    Created “Glyoxalase I”: The third nickel-dependent enzyme class in human pathogens, after urease and hydrogenase. Glyoxalase I detoxifies methylglyoxal, a reactive and toxic byproduct of glycolysis. While less well-known…

    Created “Glyoxalase I”: The third nickel-dependent enzyme class in human pathogens, after urease and hydrogenase. Glyoxalase I detoxifies methylglyoxal, a reactive and toxic byproduct of glycolysis. While less well-known… Published sections: Glyoxalase I (GloI); The glyoxalase system; Why methylglyoxal is dangerous; Two distinct GloI classes -- the metal selectivity divide; Confirmed Ni-GloI pathogens; Eukaryotic pathogens with Ni-GloI; Methylglyoxal detoxification under metabolic stress; NEC-associated pathogens; Potassium efflux; The selective inhibitor opportunity; Drug target validation in Leishmania; Broader anti-infective potential; Nickel ties GloI to the broader urease/hydrogenase story; Mis-metallation in reverse; Connections. · Karen Pendergrass · +175 −0

    Inspect exact Git diff ↗
Continue exploring

Every article is a doorway.

Generated from the WikiBiome Markdown vault and reconciled against its source registry.

6 references · 13 backlinks · 9 indexed topics